Delivery Order SPE2DB22D3004-SPE2DB25FPJ41

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,679.42, is a Firm Fixed Price Delivery Order for the supply of CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has an ultimate completion date of July 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,530.53, is a Firm Fixed Price Delivery Order for the supply of CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $143,731.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIMZIA 2X200 MG/ML SYRINGE KITS, a specialty pharmaceutical product, with a completion date of October 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,560.58 firm fixed price delivery order is for the supply of 4,566,242,301 units of the CIMZIA 2X200 MG/ML syringe kits. This contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $8,098.51 for the provision of 4567267880 CIMZIA 2X200 MG/ML SYRINGE KITS, with a completion date of February 14, 2025. The contract is a Firm Fixed Price agreement and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $15,826.22, is for the delivery of CIMZIA 2X200 MG/ML SYRINGE KITS, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,856.38, is a firm fixed-price delivery order for the supply of CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,703.42, is for the delivery of CIMZIA 2X200 MG/ML SYRINGE KITS. It is a firm fixed-price delivery order with an ultimate completion date of October 31, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,049.98 firm fixed-price delivery order is for the supply of CIMZIA 200 MG VIAL KITS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,303.44, is for the delivery of CIMZIA 2X200 MG/ML syringe kits. This is a firm-fixed-price delivery order contract that runs through January 15, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPJ41
    Delivery Order

This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPJ41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIMZIA 2X200 MG/ML SYRINGE KITS, with a ceiling value of $3,530.53 and a completion date of February 4, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/5/25, 9:58 AM